Sleep Aid with Novel Mechanism Approved
Experts offer their opinion on how Takeda's Rozerem, the first non-controlled sleep aid, will be received by doctors and patients.
Teva Advances Generics Consolidation with Ivax Purchase
Teva's recent purchase of Ivax has analysts wondering where the push for bigger and more global generic manufacturing companies will take the industry.
CAFTA Intellectual Property Provisions Stir Controversy
Generics manufacturers, public health advocates and Big Pharma square off over the implications of the Central American Free Trade Agreement.
